Apnimed

APMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.026 B

$27.00 -3.16%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#157Jade BiosciencesJBIO$1.08B
#158Olema PharmaceuticalsOLMA$1.05B
#159ApnimedAPMD$1.03B
#160Opko HealthOPK$1.02B
#161Pacira BioSciencesPCRX$997.3M

Where these numbers come from

Share counts and financials for Apnimed are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.